Sprache auswählen
Kostenlose Registrierung
Mein Warenkorb

Mogengel

Mogengel Produktliste

  • Attribut

    Extracellular Matrices (10)

  • Produktbibliothek

    Online (10)

  • Spezies

    - (10)

  • Etikett

    - (10)

  • Marker

    - (10)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
HOT
AC-M082703
-
-
Mogengel Matrix (GFR Phenol Red Free) (Acro Certified) In den Warenkorb legen
HOT
AC-M082704
-
-
Mogengel Matrix (Acro Certified) In den Warenkorb legen
HOT
AC-M082706
-
-
Mogengel Matrix (Phenol Red Free) (Acro Certified) In den Warenkorb legen
AC-M082701
-
-
Mogengel Matrix (GFR) (Acro Certified) In den Warenkorb legen
AC-M082721
-
-
Mogengel Matrix (HC GFR) (Acro Certified) In den Warenkorb legen
AC-M082723
-
-
Mogengel Matrix (HC GFR Phenol Red Free) (Acro Certified) In den Warenkorb legen
AC-M082724
-
-
Mogengel Matrix (HC) (Acro Certified) In den Warenkorb legen
AC-M082726
-
-
Mogengel Matrix (HC Phenol Red Free) (Acro Certified) In den Warenkorb legen
AC-M082755
-
-
Mogengel Matrix Organoid Culture (Acro Certified) In den Warenkorb legen
AC-M082777
-
-
Mogengel Matrix IPSC Level (Acro Certified) In den Warenkorb legen
Gesamtmenge10
  • 1

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Human apotransferrin (Sanquin Blood Supply Foundation)Phase 3 ClinicalSanquin Plasma Products BvIron Metabolism Disorders; beta-Thalassemia
Details
CX-2029ABBV-2029; ABBV-CX-2029; CX-2029Phase 2 ClinicalAbbvie Inc, Cytomx Therapeutics IncHead and Neck Neoplasms; Solid tumours; Esophageal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Non-Small-Cell Lung
Details
DYNE-251DYNE251Phase 2 ClinicalMuscular Dystrophy, Duchenne
Details
Lepunafusp alfaJR-171Phase 2 ClinicalJcr Pharmaceuticals Co LtdMucopolysaccharidosis I
Details
PPMX-T003PPMX-T003Phase 2 ClinicalPerseus Proteomics IncLeukemia; Polycythemia Vera
Details
Delpacibart eteddesiranAOC-1001Phase 2 ClinicalAvidity Biosciences IncMyotonic Disorders; Genetic Diseases, Inborn; Musculoskeletal Diseases; Muscular Disorders, Atrophic; Myotonic Dystrophy; Muscular Atrophy; Muscular Diseases; Heredodegenerative Disorders, Nervous System; Neuromuscular Diseases; Nervous System Diseases; Muscular Dystrophies; Neurodegenerative Diseases
Details
TrontinemabRO-7126209; RG-6102Phase 2 ClinicalF. Hoffmann-La Roche LtdAlzheimer Disease
Details
INA-03INA03Phase 1 ClinicalInatherysLeukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute
Details
KK-2260KK2260; KK-2260Phase 1 ClinicalKyowa Kirin Co LtdSolid tumours; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck
Details
ABX-1100ABX-1100Phase 1 ClinicalAro Biotherapeutics CoGlycogen Storage Disease Type II
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Pabinafusp alfaJR-141ApprovedJcr Pharmaceuticals Co LtdJapanMucopolysaccharidosis IIJcr Pharmaceuticals Co Ltd2021-03-23Mucopolysaccharidosis II
Details
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Teilen auf:

Mach mitRechtliche HinweiseSeitenübersichtDatenschutzrichtlinieTerms and Conditions
Website-Feedback
Kontaktieren Sie uns

+49 800 0826645

order.de@acrobiosystems.com
tech.de@acrobiosystems.com

BettinastraBe 30, 60325 Frankfurt am Main